Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5220713
Max Phase: Preclinical
Molecular Formula: C69H105N5O20S
Molecular Weight: 1356.68
Associated Items:
ID: ALA5220713
Max Phase: Preclinical
Molecular Formula: C69H105N5O20S
Molecular Weight: 1356.68
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCc5cc(O)ccc5[C@H]4CC[C@]23C)C(C)(C)C)cc1
Standard InChI: InChI=1S/C69H105N5O20S/c1-49-64(95-48-72-49)51-8-6-50(7-9-51)44-71-66(80)59-43-54(76)45-74(59)67(81)65(68(2,3)4)73-62(78)47-93-41-39-91-37-36-90-38-40-92-46-61(77)70-19-21-83-23-25-85-27-29-87-31-33-89-35-34-88-32-30-86-28-26-84-24-22-82-20-17-63(79)94-60-15-14-58-57-12-10-52-42-53(75)11-13-55(52)56(57)16-18-69(58,60)5/h6-9,11,13,42,48,54,56-60,65,75-76H,10,12,14-41,43-47H2,1-5H3,(H,70,77)(H,71,80)(H,73,78)/t54-,56-,57-,58+,59+,60+,65-,69+/m1/s1
Standard InChI Key: JFNSPELNYQFTQG-VMRJVFIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1356.68 | Molecular Weight (Monoisotopic): 1355.7074 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Li J, Cai Z, Li XW, Zhuang C.. (2022) Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives., 65 (20.0): [PMID:36205223] [10.1021/acs.jmedchem.2c01223] |
Source(1):